Loading…
← CockpitCompetitor Analysis › 4912.T Lion CorporationOpen in the cockpit ↗

Lion Corporation4912.TCompetitor analysis, valuation and peers

Japan · JPY·Consumer Staples›Household/Personal Care

Japanese household and personal care products maker selling toothpaste, laundry detergent and daily necessities.

≈ Japan's Procter & Gamble/Colgate-PalmoliveMomentum leader 96
Mkt cap
$3.85B
US dollars, full cap
Free float
83%
of shares outstanding
$/day
$19.1M
20-day average traded
Fwd P/E
24.3×
forward earnings
ROIC−WACC
+2.0 pp
WACC 5.0%
Hurdle
-3 pp
Req g minus delivered
Next earnings
92 days
18 Feb 2027
Close · JPY¥2,232
1D-1.1%
1W+5.9%
1M+19.2%
3M+17.2%
6M+44.5%
YTD+35.4%
1Y+44.3%
ATR %2.9%
52w lowhigh1.9% off high

What Lion does

Japanese household and personal care products maker selling toothpaste, laundry detergent and daily necessities.

Wins shelf space with supermarkets and drugstores through frequent product launches and heavy advertising, with oral care its strongest category in Japan. Outside Japan it sells mainly in Southeast Asia and Korea.

In one line: Japan's Procter & Gamble/Colgate-Palmolive.

Products and services

  • Toothpaste/oral care
  • Laundry detergent
  • Household cleaning products

Customers

  • Retail grocery/drugstore consumers

Where it sits in the supply chain

  • Consumer staples
  • Household & personal care
  • Oral care, laundry detergent…

What could go right

  • Household/personal care demand stability

What could go wrong

  • Raw material (petrochemical) cost inflation
  • Category competition from Kao

Moat: narrow (brand, scale, distribution). Long-standing household brand recognition and retail distribution scale in Japan.

Headquarters: Tokyo, Japan · Founded: 1891 · Employees: 8,346

Named competitors

Lion at a glance

Size Lion (4912.T) is a Japan Consumer Staples company (Household/Personal Care) with a market value of $3.85B, the 305th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥2,232 on 18 Nov 2026.

Performance Over six months the shares gained 44.5%, against -2.5% for the median peer and -1.4% for the Japan market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue grew 6.2% over the last twelve months (peer median +5.7%); the operating margin is 7.7% (peer median 13.8%).

Valuation It trades at 24.3× forward earnings against a peer median of 18.8× (8th most expensive of 20).

Price implies For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.0 points above its cost of capital (5.0% WACC).

Next results Next results expected around 18 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 20264912.T 142Peer median 101
Six months, rebased to 100: Lion against the median of its 20 peers (local-currency closes).

Lion financials

Reported figures in JPY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥443B¥422B¥413B¥403B¥390B
Revenue growth—+2%+3%+3%—
Gross profit¥206B¥194B¥189B¥181B¥175B
EBITDA¥57.2B¥51.9B¥46.8B¥39.6B¥40.9B
Net income¥24.8B¥27.6B¥21.2B¥14.6B¥21.9B
Free cash flow¥35.1B¥22.6B¥25.6B¥6.34B¥23.5B
Capital expenditure¥10.9B¥19.3B¥19.0B¥25.0B¥23.1B
Total debt¥31.2B¥28.2B¥29.7B¥30.3B¥32.2B

Quarterly statements and history in the cockpit →

Lion competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%0%+20%4527COTYITP104449671318COLPAL603605CUPID051900REYNGILLETTE3008881928202367PGHH278470ELF26984912.T6-month return →1-month return →
Up and to the right = strong over both horizons. Lion is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%20×40×4527COTYITP104449671318COLPAL603605051900GILLETTE3008881928202367090430278470ELF26984912.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Lion is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%4527COTYITP104449671318COLPAL603605051900REYNGILLETTE2367090430PGHH278470ELF26984912.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Lion is the large dot.

Lion competitors and peer comparison

Head to head with its named competitors (4912.T vs 4452.T vs PG vs CL)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Lion 4912.T$3.85B+44%+6%8%24.3×0.9%
Kao 4452.T$22.7B+39%+6%10%25.6×1.5%
Procter & Gamble PG$395B+20%+4%24%24.1×0.5%
Colgate-Palmolive CL$78.6B+9%+6%22%24.7×-4.9%

How Lion compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Lion against its 20 peers (data as of 18 Nov 2026)
Measure4912.TPeer medianRank in peer set
1-month return+19.2%-1.9%2nd highest of 21
6-month return+44.5%-2.5%6th highest of 21
Distance from 52-week high-1.9%-21.6%highest of 21
Revenue growth (TTM)+6.2%+5.7%11th highest of 21
Operating margin7.7%13.8%4th lowest of 21
Forward P/E24.3×18.8×8th most expensive of 20
Growth the price implies (Req g, 7 yrs)0.9%3.9%9th least demanding of 19
Growth delivered (Del g)+3.5%+10.2%7th lowest of 19
Hurdle (Req g minus delivered)-2.6 pp-3.3 pp10th least demanding of 19
ROIC minus cost of capital+2.0 pp+5.3 pp6th lowest of 19
EV / EBITDA10.4×13.2×6th cheapest of 18
Net debt / EBITDA-0.8×-0.6×8th least indebted of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Lion 4912.TJapan$3.85B+44%+6%8%24.3×0.9%+3.5%
Rohto Pharmaceutical 4527.TJapan$3.87B+8%+7%12%16.5×-2.8%+13.7%
Coty COTYUnited States$3.71B+116%0%5%13.5×9.8%+4.6%
Interparfums ITP.PAFrance$3.49B+66%-4%18%26.9×15.6%+19.6%
Hengan Int'l 1044.HKHong Kong$3.27B-12%+2%11%9.1×-8.2%-0.1%
Kobayashi Pharmaceutical 4967.TJapan$3.25B+20%+2%6%48.7×18.0%+1.9%
Mao Geping Cosmetics 1318.HKHong Kong$4.67B-8%+32%31%14.3×4.1%+41.1%
Colgate-Palmolive (India) COLPAL.NSIndia$4.91B-23%+9%28%32.4×31.1%+4.5%
Proya Cosmetics 603605.SSChina$2.87B-13%+2%13%10.9×-5.3%+23.1%
Cupid CUPID.NSIndia$5.22B+218%+125%33%n/an/an/a
LG H&h 051900.KSSouth Korea$2.81B-14%-3%3%23.1×-4.6%-4.1%
Reynolds Consumer Products REYNUnited States$5.28B+15%+2%14%15.3×0.8%+2.7%
Gillette India GILLETTE.NSIndia$2.53B-5%+8%28%37.1×14.9%+13.0%
Winner Medical 300888.SZChina$2.53B-6%+4%11%19.9×-5.2%-2.6%
Cosmax 192820.KSSouth Korea$2.51B+53%+25%8%18.8×n/an/a
Giant Biogene 2367.HKHong Kong$2.47B-32%-10%32%8.6×-10.7%+34.9%
Amorepacific 090430.KSSouth Korea$6.01B0%+10%9%24.4×3.6%-0.8%
Procter & Gamble Hygiene & Health Care PGHH.NSIndia$2.37B-30%-2%24%27.0×21.2%+7.4%
APR 278470.KSSouth Korea$6.66B-45%+119%24%16.2×-2.3%+47.3%
e.l.f. Beauty ELFUnited States$6.73B+124%+40%14%34.3×24.1%+38.8%
Softcare 2698.HKHong Kong$2.20B+5%+25%25%14.4×9.1%+20.9%

Questions

Who are Lion's main competitors?
Named competitors: Kao Corporation (4452.T), Procter & Gamble (PG), Colgate-Palmolive (CL). The cockpit's measured peer set (industry) also includes Rohto Pharmaceutical (4527.T), Coty (COTY), Interparfums (ITP.PA), Hengan Int'l (1044.HK), Kobayashi Pharmaceutical (4967.T), Mao Geping Cosmetics (1318.HK).
Is Lion expensive compared with its peers?
On forward p/e it trades at 24.3× against a peer median of 18.8×, 8th most expensive of 20 in its peer set. For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Lion stock performed?
Over six months to 18 Nov 2026 the shares returned +44.5% against -2.5% for the median peer; over one year +44.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.